Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).

Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Pharmazie (Impact Factor: 1). 06/1994; 49(5):336-9.
Source: PubMed

ABSTRACT C31G is a specific formulation which contains equal molar concentrations of alkyl N-betaine and alkyl N,N-dimethylamine oxide. Vaginal suppositories containing 500 mg of C31G, this potent antimicrobial substance, were prepared by the fusion method in a variety of Suppocire and Witepsol bases with different melting points and hydroxyl values. In vitro release and diffusion characteristics of C31G from different suppository bases were investigated using two different systems. The release from suppositories was determined by using a system without a membrane and the diffusion rate of the released agent was determined through a semipermeable dialyzing tubing. Diffusion kinetics from suppositories were evaluated in terms of the apparent dialytic rate constants using the equation developed by Davis et al. From the results of in vitro studies, Witepsol H15 and Suppocire CM bases were selected as the most suitable ones for the formulations of C31G vaginal suppositories, since it is imperative for topical formulations to release the active substance in high proportions which are not absorbable by the mucosal membranes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vaginal delivery is an important route of drug administration for both local and systemic diseases. The vaginal route has some advantages due to its large surface area, rich blood supply, avoidance of the first-pass effect, relatively high permeability to many drugs and self-insertion. The traditional commercial preparations, such as creams, foams, gels, irrigations and tablets, are known to reside in the vaginal cavity for a relatively short period of time owing to the self-cleaning action of the vaginal tract, and often require multiple daily doses to ensure the desired therapeutic effect. The vaginal route appears to be highly appropriate for bioadhesive drug delivery systems in order to retain drugs for treating largely local conditions, or for use in contraception. In particular, protection against sexually-transmitted diseases is critical. To prolong the residence time in the vaginal cavity, bioadhesive therapeutic systems have been developed in the form of semi-solid and solid dosage forms. The most commonly used mucoadhesive polymers that are capable of forming hydrogels are synthetic polyacrylates, polycarbophil, chitosan, cellulose derivatives (hydroxyethycellulose, hydroxy-propylcellulose and hydroxypropylmethylcellulose), hyaluronic acid derivatives, pectin, tragacanth, carrageenan and sodium alginate. The present article is a comprehensive review of the patents related to mucoadhesive vaginal drug delivery systems.
    11/2009; 3(3):193-205. DOI:10.2174/187221109789105658
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paracetamol is commercially available in oral and rectal dosage forms for geriatric and pediatric patients. Limitation of oral drug delivery for pediatric patient is inconvenience to swallow the tablet, capsule and oral suspension; in such case suppositories are effective and often used. To achieve successful delivery of drug locally as well as systematically, rectal route has proved its potential. The main objective of this research was to evaluate the potential of Suppocire suppository bases and study the effect of incorporation of ionic and nonionic surfactants on in-vitro release characteristic of paracetamol. Suppocire bases evaluated were interesterified Suppocire bases (Std type) e.g. Suppocire D and C, esterified bases (N-type) e.g. Suppocire NCX and amphiphilic bases (P-type) e.g. Suppocire CP. Effect of various additives such as sodium lauryl sulfate (SLS), dioctyl sulfosuccinate (DOSS), Labrasol, lecithin, Miglyol 812, aerosil, Capryol PGMC (CPGMC) and span 80 were studied on drug release. Paracetamol Suppocire suppository using amphiphilic base in combination with Labrasol showed optimal drug release as compared to other Suppocire bases. The developed paracetamol Suppocire suppositories gave controlled as well as fast release depending upon the additives added to the formulation and proved to be a good suppository base. Newly incorporated additives such as Labrasol and Capryol PGMC have promise to be used as adjuvants in suppository formulation.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The main aim of this work was to develop rectal suppositories for better delivery of metoprolol tartrate (MT). The various bases used were fatty, water soluble and emulsion bases. The physical properties of the prepared suppositories were characterized such as weight variation, hardness, disintegration time, melting range and the drug content uniformity. The in vitro release of MT from the prepared suppositories was carried out. The evaluation of the pharmacological effects of MT on the blood pressure and heart rate of the healthy rabbits after the rectal administration compared to the oral tablets was studied. Moreover, the formulation with the highest in vitro release and the highest pharmacological effects would be selected for a further pharmacokinetics study compared to the oral tablets. The results revealed that the emulsion bases gave the highest rate of the drug release than the other bases used. The reduction effect of the emulsion MT suppository base on the blood pressure and heart rate was found to be faster and greater than that administered orally. The selected emulsion suppository base (F11) showed a significant increase in the AUC (1.88-fold) in rabbits as compared to the oral tablets. From the above results we can conclude that rectal route can serve as an efficient alternative route to the oral one for systemic delivery of MT which may be due to the avoidance of first-pass effect in the liver.
    Drug Delivery 04/2014; DOI:10.3109/10717544.2014.904021 · 2.20 Impact Factor


Available from